IOL CHEMICALS EXPANDSPRODUCTION CAPACITY

• Company setting up a new manufacturing unit for Ibuprofen with an installed capacity of 6,000 MT per annum. • This will enhance existing Ibuprofen capacity from 12,000 MT to 18,000 MT per annum upon commissioning. • Estimated project cost is ₹350 Cr, to be funded through internal accruals. • The company has also installed a new pharmaceutical formulation manufacturing facility for Contract Development and Manufacturing Organisation (CDMO) business. • This facility has a capacity of 1,500 million tablets per annum, with an estimated project cost of ₹110 Cr, funded through internal accruals. • A dedicated specialty chemicals manufacturing facility is also being established under a long-term tolling arrangement. • This project entails an estimated capital expenditure of ₹35 Cr, funded through internal accruals.

IOL Chemicals & Pharmaceuticals Ltd

Open attachment

← Back to feed